ACS Materials Letters,
Journal Year:
2024,
Volume and Issue:
6(3), P. 985 - 998
Published: Feb. 15, 2024
Ferroptosis-based
therapy
exhibits
promising
prospects
for
the
treatment
of
malignant
tumors.
However,
practical
therapeutic
benefits
ferroptosis-based
antitumor
are
usually
restricted
by
excess
endogenous
antioxidants
and
relatively
sluggish
ROS
production
kinetics.
Here,
an
activatable
plasmonic
versatile
nanoplatform
(AuSi@FePB)
with
glutathione
(GSH)-depletion
capacity
is
reported
synergistic
ferroptosis
second
near-infrared
window
photothermal
(NIR-II
PTT).
The
stability
in
physiological
conditions,
but
tumor
microenvironment,
its
Fe-PDA
shell
gradually
disintegrates
to
increase
intracellular
ferrous
supply
elevated
generation
GSH-depletion
response
overexpressed
GSH,
leading
amplified
cells.
integration
NIR-II
laser
irradiation
facilitates
localized
heat,
which
not
only
effectively
triggers
also
significantly
enhances
Fenton
reaction,
thereby
promoting
ferroptotic
cell
death
While
oxidative
damage
can
downregulate
heat
repair
effect,
facilitating
PTT
efficacy.
More
importantly,
such
synergism
results
elimination
primary
a
systemic
immune
response,
regression
nontreated
distant
tumors
impeding
occurrence
lung
metastasis.
vivo
mechanism
was
further
verified
transcriptome
sequencing,
demonstrating
that
augmented
effective
combination
strategy.
This
study
presents
perspective
cancer
based
on
sheds
new
light
novel
platforms
future
therapy.
Advanced Materials,
Journal Year:
2024,
Volume and Issue:
36(26)
Published: March 29, 2024
Abstract
Sonodynamic
therapy
(SDT)
is
applied
to
bladder
cancer
(BC)
given
its
advantages
of
high
depth
tissue
penetration
and
nontoxicity
due
the
unique
anatomical
location
near
abdominal
surface.
However,
low
electron–hole
separation
efficiency
wide
bandgap
sonosensitizers
limit
effectiveness
SDT.
This
study
aims
develop
a
TiO
2
‐Ru‐PEG
Schottky
heterojunction
sonosensitizer
with
narrow
for
SDT
in
BC.
Density
functional
theory
(DFT)
calculations
experiments
collectively
demonstrate
that
reduced
characteristic
crystalline‐amorphous
interface
formed
by
deposition
ruthenium
(Ru)
within
shell
layer
.
Thanks
enhancement
oxygen
adsorption
efficient
pairs,
promotes
generation
reactive
species
(ROS)
under
ultrasound
(US)
irradiation,
resulting
cell
cycle
arrest
apoptosis
tumor
cells.
The
vivo
results
prove
boosted
subcutaneous
orthotopic
models
while
exhibiting
good
safety.
adopts
complex
optimizing
sonosensitizers,
contributing
progress
improvement
strategies
presenting
paradigm
BC
therapy.
Advanced Functional Materials,
Journal Year:
2024,
Volume and Issue:
34(37)
Published: April 25, 2024
Abstract
Cuproptosis
and
ferroptosis
hold
great
promise
for
overcoming
apoptotic
resistance
in
liver
cancer
based
on
their
unique
metal‐driven
cell
death
modalities.
However,
insufficient
intracellular
copper
iron
concentration,
complicated
tumor
microenvironment
(TME),
unclear
cross‐regulatory
mechanisms
between
cuproptosis
ferroptosis,
severely
restrict
the
therapeutic
performance.
Herein,
copper‐doped
hollow
Prussian
blue
(CHP)
nanozymes
are
rationally
designed
loading
photosensitizer
indocyanine
green
(ICG)
O
2
‐saturated
perfluorohexane
(PFH),
denoted
as
‐PFH@CHPI
nanoparticles,
to
induce
ferroptosis.
In
response
specific
TME,
CHP
can
synergistically
catalyze
Fenton
reactions
consume
endogenous
glutathione,
leading
accumulation
of
reactive
oxygen
species.
Upon
near‐infrared
irradiation,
‐PFH@CHPI‐enabled
photothermal
effect
simultaneously
accelerate
catalytic
trigger
release
photodynamic
therapy
promote
oxidative
stress.
Notably,
be
effectively
activated
through
Cu
+
‐mediated
dihydrolipoamide
S‐acetyltransferase
aggregation
Fe–S
cluster
protein
loss.
Concurrently,
tilt
redox
balance
is
favorable
lipid
peroxidation
glutathione
peroxidase
4
inactivation,
resulting
an
augmented
effect.
Mechanistically,
stress‐boosted
jointly
disrupt
mitochondrial
metabolism,
which
turn
exacerbates
stress,
thus
realizing
a
mutually
enhanced
This
work
may
provide
new
guidance
utilizing
copper/ferrous‐engineering
cuproptosis/ferroptosis
synergetic
therapy.
Advanced Functional Materials,
Journal Year:
2024,
Volume and Issue:
34(21)
Published: Jan. 30, 2024
Abstract
Rescuing
dental
implants
from
plaque‐induced
infection
and
implementing
effective
plaque
control
methods
in
a
limited
oral
environment
pose
challenges
for
modern
dentistry.
To
address
this
issue,
Al
ion
doped
strontium
titanate/titanium
dioxide
nanotubes
(Al‐SrTiO
3
/TiO
2
nanotubes,
Al‐STNT)
are
designed
as
an
ultrasound‐responsive
nanocoating
immobilized
on
the
Ti
implant
surface.
Introducing
3+
ions
into
inorganic
sonosensitive
SrTiO
heterojunction
induces
oxygen
vacancies
disrupts
lattice
of
.
By
overcoming
bandgap
barrier
through
ultrasonic
stimulated
piezoelectric
effect,
Al‐STNT
produces
more
reactive
species
(ROS).
In
sonodynamic
therapy
(SDT)
process,
stimulus
abundant
ROS
efficiently
disrupting
bacteria
biofilm
inhibiting
metabolism.
Moreover,
specific
nanoscale
coating
endows
with
osteogenic
activity,
facilitating
formation
rigid
osseointegration
between
surface
alveolar
bone.
mimicking
human
rats,
demonstrates
optimal
postimplant
while
retaining
its
antibacterial
ability
sonosensitizer.
Thanks
to
portability
ultrasound
instrument
stability
implant‐based
sonosensitizer,
strategy
presents
attractive
option
patients
self‐treat
secure
long‐term
success
their
implants.
Advanced Functional Materials,
Journal Year:
2024,
Volume and Issue:
34(26)
Published: Feb. 27, 2024
Abstract
Reactive
oxygen
species
(ROS)‐induced
endoplasmic
reticulum
(ER)
stress
in
sonodynamic
therapy
(SDT)
can
elicit
immunogenic
cell
death
(ICD)‐initiated
antitumor
immunity
for
augmented
sono‐immunotherapy.
However,
unsatisfactory
activity
and
mediocre
ER
induction
ability
of
sonosensitizers
essentially
restrict
SDT
efficacy
ICD
stimulation.
Herein,
a
versatile
ER‐targeting
Iridium(III)
nanosonosensitizer
is
developed
as
superior
inducer
boosted
tumor
An
ingenious
cholic
acid
(CA)‐functionalized
sonosensitizer
Ir‐CA
well‐designed
skillfully
crosslinked
with
human
serum
albumin
(HSA)
to
form
HSA@Ir‐CA.
With
high
stability,
favorable
tumor‐targeting
ability,
reduction‐responsiveness,
HSA@Ir‐CA
preferentially
accumulates
sites
enhanced
cellular
uptake,
followed
by
rapid
disassembly
responding
intracellular
reductive
environment.
The
uncaged
selectively
accumulate
precisely
disrupt
situ
produced
type
I
II
ROS
upon
US
irradiation
high‐efficiency
SDT.
Moreover,
the
maximized
eminently
amplifies
evoke
robust
systemic
immunity,
inhibiting
growths
primary/distant
tumor,
lung
metastasis,
recurrence.
This
combined
immune
checkpoint
inhibitor
(αPD‐L1)
further
achieves
reinforced
therapeutic
outcome
against
immunologically
“cold”
tumor.
study
presents
an
effective
paradigm
optimize
amplify
ICD‐initiated
responses
Angewandte Chemie International Edition,
Journal Year:
2024,
Volume and Issue:
64(1)
Published: Aug. 22, 2024
Single-atom
nanozymes
(SAzymes)
with
ultrahigh
atom
utilization
efficiency
have
been
extensively
applied
in
reactive
oxygen
species
(ROS)-mediated
cancer
therapy.
However,
the
high
energy
barriers
of
reaction
intermediates
on
single-atom
sites
and
overexpressed
antioxidants
tumor
microenvironment
restrict
amplification
oxidative
stress,
resulting
unsatisfactory
therapeutic
efficacy.
Herein,
we
report
a
multi-enzyme
mimetic
MoCu
dual-atom
nanozyme
(MoCu
DAzyme)
various
catalytic
active
sites,
which
exhibits
peroxidase,
oxidase,
glutathione
(GSH)
nicotinamide
adenine
dinucleotide
phosphate
(NADPH)
oxidase
mimicking
activities.
Compared
Mo
SAzyme,
introduction
Cu
atoms,
formation
synergetic
effects
among
enhance
substrate
adsorption
reduce
barrier,
thereby
endowing
DAzyme
stronger
Benefiting
from
above
enzyme-like
activities,
can
not
only
generate
multiple
ROS,
but
also
deplete
GSH
block
its
regeneration
to
trigger
cascade
stress.
Additionally,
strong
optical
absorption
near-infrared
II
bio-window
endows
remarkable
photothermal
conversion
performance.
Consequently,
achieves
high-efficiency
synergistic
treatment
incorporating
collaborative
therapy
This
work
will
advance
applications
DAzymes
provide
valuable
insights
for
nanocatalytic
Chemical Reviews,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 14, 2025
Ferroptosis,
an
iron-dependent
form
of
regulatory
cell
death,
has
garnered
significant
interest
as
a
therapeutic
target
in
cancer
treatment
due
to
its
distinct
characteristics,
including
lipid
peroxide
generation
and
redox
imbalance.
However,
clinical
application
oncology
is
currently
limited
by
issues
such
suboptimal
efficacy
potential
off-target
effects.
The
advent
nanotechnology
provided
new
way
for
overcoming
these
challenges
through
the
development
activatable
magnetic
nanoparticles
(MNPs).
These
innovative
MNPs
are
designed
improve
specificity
ferroptosis
induction.
This
Review
delves
into
chemical
biological
principles
guiding
design
ferroptosis-based
therapies
imaging-guided
therapies.
It
discusses
mechanisms
attributes
ferroptosis,
composition
MNPs,
their
mechanism
action
inducers,
integration
with
advanced
imaging
techniques
monitoring.
Additionally,
we
examine
convergence
other
strategies,
chemodynamic
therapy,
photothermal
photodynamic
sonodynamic
immunotherapy,
within
context
nanomedicine
strategies
utilizing
MNPs.
highlights
multifunctional
surpass
limitations
conventional
treatments,
envisioning
future
drug-resistance-free,
precision
diagnostics
treating
recalcitrant
cancers.
Advanced Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 8, 2025
Sonodynamic
therapy
(SDT)
represents
a
promising
approach
for
cancer
treatment.
Compared
to
photodynamic
therapy,
SDT
offers
increased
penetration
depth
and
higher
precision.
However,
the
practical
application
of
is
constrained
by
low
water
solubility,
poor
tumor
specificity,
metabolic
susceptibility
most
sonosensitizers.
Recent
research
has
explored
use
piezoelectric
materials
as
sonosensitizers
in
treatment
inhibition
bacterial
growth.
Upon
ultrasound
excitation,
separation
electron-hole
(e--h+)
pairs
occurs
within
material.
By
improving
crystal
structure
material
or
incorporating
other
nanoparticles
prevent
rapid
recombination
e--h+
pairs,
accumulates
charges
conduction
band
valence
band,
achieving
redox
potential
O2/·O2
-.
This
enables
serve
sonosensitizer,
leading
concept
termed
Sono-Piezo
Dynamic
Therapy
(SPDT).
review
aims
define
SPDT,
provide
systematic
overview
historical
development
SDT,
elucidate
mechanisms
which
act
Importantly,
various
will
be
discussed
terms
their
feasibility,
advantages,
disadvantages
sonosensitizers,
offering
new
perspectives
identifying
Nature Communications,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: March 11, 2025
Single-atom
catalysts
(SACs)
are
emerging
as
potent
tools
for
the
selective
regulation
of
active
species,
offering
substantial
promise
green
and
sustainable
Fenton
catalysis.
However,
current
SACs
face
limitations
due
to
specificity
their
supports,
which
only
allow
within
certain
oxidant
systems.
This
constraint
makes
targeted
across
different
systems
challenging.
In
response,
this
study
designs
a
SAC,
termed
CoSAs-ZnO,
featuring
surface
hydroxylation
an
isolated
asymmetric
Co-O-Zn
configuration.
SAC
can
realize
nearly
100%
generation
sulfate
radicals
(SO4•−)
singlet
oxygen
(1O2)
in
peroxymonosulfate
(PMS)
peracetic
acid
(PAA)
systems,
respectively.
Moreover,
PMS-activated
system
efficiently
treat
electron-deficient-dominated
refractory
benzoic
wastewater,
achieving
100.0%
removal
multiple
consecutive
pilot-scale
experiments.
The
PAA-activated
facilitates
rapid
conversion
benzyl
alcohol
benzaldehyde,
with
high
selectivity
89.0%.
Detailed
DFT
calculations
reveal
that
hydroxyl
groups
on
ZnO
play
critical
role
modulating
adsorption
configurations
oxidants,
thus
enabling
specific
species
each
system.
provides
insights
into
design
multifunctional
applications
paves
way
deployment
wastewater
treatment
high-value
chemical
conversion.
supports.
Here,
authors
synthesised
selectively
generate